Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
about
In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders.Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic reviewA 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseasesAdult ADHD and Comorbid Somatic Disease: A Systematic Literature Review.Inherited Metabolic Disorders: Aspects of Chronic Nutrition Management.A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 1: isolated methylmalonic acidemias.Two homozygous mutations in the exon 5 of BCKDHB gene that may cause the classic form of maple syrup urine disease.Neurocognitive profiles in MSUD school-age patients.Interactions in the Metabolism of Glutamate and the Branched-Chain Amino Acids and Ketoacids in the CNS.Branched-Chain Amino Acids and Brain Metabolism.Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.Maple syrup urine disease: mechanisms and management.BCAA Metabolism and NH3 Homeostasis.Chronic activation of mTOR complex 1 by branched chain amino acids and organ hypertrophy.Impact of pregnancy on inborn errors of metabolism
P2860
Q31028468-BCC69FD4-6772-4F98-9AE7-6D9B023889E6Q33617530-2890E5B9-297A-42ED-8EA8-358C72AADC3EQ33947369-D9758FE6-7F33-4531-B017-CDCB1A0066AFQ34222287-9B41B4F5-AAE3-48FB-9FA6-E94C0F4B65C6Q34446836-B9699039-530E-430D-AF6F-1EE3E5010153Q34496202-7DF3AEE4-867E-4022-A6DF-64C2978DCD5AQ34541036-0159FE26-A4DA-4EE2-B21E-925E70E17DF8Q35889337-2AC7B98D-0A4C-4696-A948-8D45C15A2404Q36578215-12E44347-792A-4B4E-9EDD-B58F7105D867Q38757486-B95962C6-9C0F-47CB-BDDD-DF31BB301734Q38890001-F216FF83-9A53-4811-B99E-110666B4BF4AQ38970511-C49DED0B-67F1-4838-BEA6-2E109323D53EQ39247363-5F8E1791-D22D-4B06-BE10-D451684F2E62Q39359596-6CFCA52C-8F24-4E9B-8DA7-9E10BE1958F3Q40047282-3A72E4BF-6C5E-407C-9020-051594055715Q41355931-C3DEE99F-7505-4652-9F6E-96DA6DAC0B8EQ46454853-4482DED3-CE32-4F13-A930-1E8E8BFD4809Q53602337-E791E028-2308-42B4-B1A2-9B1ACCDE07B9Q58752732-A856E858-AB29-45BB-BB28-0B61C0A85E5E
P2860
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
@ast
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
@en
type
label
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
@ast
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
@en
prefLabel
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
@ast
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
@en
P2093
P2860
P356
P1476
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
@en
P2093
D Holmes Morton
Don C Bigler
Emilie R Muelly
Gregory J Moore
Julie Mack
Kevin A Strauss
Scott C Bunce
P2860
P304
P356
10.1172/JCI67217
P407
P577
2013-03-08T00:00:00Z